Invivyd (IVVD) Liabilities and Shareholders Equity (2020 - 2026)
Invivyd (IVVD) reported Liabilities and Shareholders Equity of $218.88 million for Q2 2026, up 145.6% from $89.14 million a year earlier.
Invivyd (IVVD) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Invivyd posted Liabilities and Shareholders Equity of $276.88 million, up 113.8% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 18.7% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $129.52 million in FY2024 (-43.5%), $229.18 million in FY2023 (-40.2%), $383.17 million in FY2022 (-38.2%) and $620.09 million in FY2021 (+428.3%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $89.14 million in Q2 2025 and a high of $686.27 million in Q3 2021.
- Year over year, Liabilities and Shareholders Equity gained in two of the last seven quarters, with growth averaging 8.4%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 428.3%); the low point was Q1 2025 (a decline of 51.9%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Invivyd | 256.44 Mn | -250.20 Mn | 13.01 Mn | 218.88 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 218.88 Mn |
| Dec 31, 2025 | 276.88 Mn |
| Sep 30, 2025 | 139.16 Mn |
| Jun 30, 2025 | 89.14 Mn |
| Mar 31, 2025 | 103.74 Mn |
| Dec 31, 2024 | 129.52 Mn |
| Sep 30, 2024 | 161.92 Mn |
| Jun 30, 2024 | 177.35 Mn |
| Mar 31, 2024 | 215.47 Mn |
| Dec 31, 2023 | 229.18 Mn |
| Sep 30, 2023 | 274.92 Mn |
| Jun 30, 2023 | 315.41 Mn |
| Mar 31, 2023 | 350.56 Mn |
| Dec 31, 2022 | 383.17 Mn |
| Sep 30, 2022 | 424.75 Mn |
| Jun 30, 2022 | 484.61 Mn |
| Mar 31, 2022 | 556.27 Mn |
| Dec 31, 2021 | 620.09 Mn |
| Sep 30, 2021 | 686.27 Mn |
| Jun 30, 2021 | 397.99 Mn |
Invivyd Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IVVD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();